Form 8-K - Current report:
SEC Accession No. 0001193125-26-324860
Filing Date
2026-07-30
Accepted
2026-07-30 07:01:25
Documents
10
Period of Report
2026-07-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K neog-20260730.htm   iXBRL 8-K 51503
2 EX-99.1 neog-ex99_1.htm EX-99.1 1544085
  Complete submission text file 0001193125-26-324860.txt   1766570

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT neog-20260730.xsd EX-101.SCH 30832
14 EXTRACTED XBRL INSTANCE DOCUMENT neog-20260730_htm.xml XML 4728
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Filer) CIK: 0000711377 (see all company filings)

EIN.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 000-17988 | Film No.: 261220120
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)